Last updated: Wed, Oct 21, 2026, 1:00 PM IST · mainboard IPO · NSE & BSE · Day 1 of 3
- Paras Healthcare IPO subscribed 0.08x overall on Day 1
- Total bids: 9,83,430 shares against 1,20,83,331 shares on offer
- Category-wise: QIB 0.00x, NII 0.04x, Retail 0.39x
- Price band: ₹660 to ₹693 per share
- The issue closes on Fri, Oct 23, 2026
The Paras Healthcare IPO opened for subscription on Wednesday, October 21, 2026. As of 1:00 PM IST on day one, the issue recorded an overall subscription multiple of 0.08x. The subscription multiple represents the total number of shares bid for divided by the total number of shares offered to the public. Retail investors emerged as the most active category at 0.39x, while other segments remained in the early stages of bidding.
Paras Healthcare IPO Subscription Status: Day 1
Day-wise subscription
| Day | Date | Total bids (shares) | Bid value at upper band (₹ crore) | Subscribed (x) |
|---|---|---|---|---|
| Day 1 | Wed, Oct 21, 2026 | 9,83,430 | 68.15 | 0.08x |
Category-wise subscription
| Category | Shares offered | Day 1 bids | Day 1 (x) |
|---|---|---|---|
| QIB | 65,90,908 | 294 | 0.00x |
| NII | 32,95,454 | 1,22,220 | 0.04x |
| of which individual NII | — | 1,18,398 | — |
| of which corporate NII | — | 1,470 | — |
| of which other NII | — | 2,352 | — |
| Retail | 21,96,969 | 8,60,916 | 0.39x |
| Total | 1,20,83,331 | 9,83,430 | 0.08x |
The retail category led the subscription process with 8,60,916 bids against 21,96,969 shares offered. Non-institutional investors, which include individuals bidding above ₹2 lakh, recorded a subscription of 0.04x. Qualified institutional buyers, or large financial institutions like banks and mutual funds, recorded 0.00x subscription. Total bids across all categories reached 9,83,430 shares during the first day of the offer.
Intraday subscription
| As of | Total bids (shares) | Total (x) | QIB (x) | NII (x) | Retail (x) |
|---|---|---|---|---|---|
| 11:00 AM | 3,70,671 | 0.03x | — | 0.01x | 0.15x |
| 1:00 PM | 9,83,430 | 0.08x | 0.00x | 0.04x | 0.39x |
Paras Healthcare IPO Offer Details
| Field | Value |
|---|---|
| IPO date | Wed, Oct 21, 2026 to Fri, Oct 23, 2026 |
| Listing date | To be announced |
| Face value | ₹1 per share |
| Price band | ₹660 to ₹693 per share |
| Lot size | 21 shares |
| Total issue size | 2,09,23,520 shares (₹837 crore) |
| Listing at | NSE & BSE |
| Lead managers | JM Financial Ltd., BofA Securities India Ltd., Nuvama Wealth Management Ltd. |
| Registrar | MUFG Intime India Pvt Ltd. |
About Paras Healthcare
Paras Healthcare Ltd. is a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services. As per the DRHP, the company operates a network of eight hospitals with an aggregate bed capacity of 2,211 beds as of June 30, 2026. Operating under the Paras Health brand, the company serves North India, Bihar, and Jharkhand. Its services cater to self-pay patients, insurance providers, and government schemes. The company focuses on clinical specialties including cardiac sciences, oncology, and neuro sciences. It maintains an asset-light business model while providing specialized medical care in Tier 2 and 3 cities.
Paras Healthcare Financial Highlights
| Metric | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Revenue from operations (₹ crore) | 1,605.95 | 1,294.06 | 1,129.04 |
| Total income (₹ crore) | 1,628.78 | 1,314.21 | 1,164.41 |
| Profit after tax (₹ crore) | 43.83 | -57.98 | -15.33 |
| Net worth (₹ crore) | 394.94 | 280.49 | 338.51 |
| Total borrowings (₹ crore) | 323.43 | 227.55 | 148.38 |
| EPS (₹) | 4.34 | -5.94 | -1.57 |
Revenue from operations grew to ₹1,605.95 crore in FY 2025-26 from ₹1,294.06 crore in FY 2024-25. Profit after tax reached ₹43.83 crore in FY 2025-26, following a loss of ₹57.98 crore in FY 2024-25. The company reported a debt-to-equity ratio of 0.82x for FY 2025-26.
Objects of the Issue
| Purpose | Amount (₹ crore) |
|---|---|
| Prepayment or scheduled re-payment of a portion of certain outstanding borrowings availed by our Com | 320.90 |
| Investment in our wholly owned Subsidiary, PMHPL (which also operates our hospital in Srinagar) | 54.10 |
Risk Factors as per the DRHP
- The company faces risks from outstanding legal proceedings involving the entity, its subsidiaries, promoter, and directors, which could impact its financial position or reputation.
- Operations rely on third-party suppliers, with the top 10 suppliers accounting for a significant portion of the company’s total supplies and medical equipment.
- The hospital chain operates in a highly regulated industry that is subject to specific pricing norms and potential changes in healthcare laws.
- The business is exposed to operational risks including fire, natural disasters such as flooding, and potential medical negligence claims from patients.
- The company may face a potential inability to pass on increased operational costs to patients due to the impact of inflation.
How to Check Paras Healthcare IPO Subscription Status
Live bidding figures are published by NSE & BSE while the issue is open. Once it closes, allotment status is published by the registrar, MUFG Intime India Pvt Ltd. (https://in.mpms.mufg.com/).
This article is for information only and is not investment advice. Subscription figures are based on exchange data as of Wed, Oct 21, 2026, 1:00 PM IST and can change. IPO investments are subject to market risks; read the offer document carefully before investing.